Hepatitis C:: molecular virology and antiviral targets

被引：51

作者：

Moradpour, D ^{[1
]}

Brass, V ^{[1
]}

Gosert, R ^{[1
]}

Wölk, B ^{[1
]}

Blum, HE ^{[1
]}

机构：

[1] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany

来源：

TRENDS IN MOLECULAR MEDICINE | 2002年 / 8卷 / 10期

关键词：

D O I：

10.1016/S1471-4914(02)02395-X

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Chronic hepatitis C is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Although current treatment options are limited, progress in understanding the molecular virology of hepatitis C has led to the identification of novel antiviral targets. Moreover, in vitro and in vivo model systems have been developed that allow systematic evaluation of new therapeutic strategies. This review details current concepts in molecular virology and emerging therapies for hepatitis C.

引用

页码：476 / 482

页数：7

共 73 条

[31] Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells
Ikeda, M
Yi, MK
Li, K
Lemon, SA
[J]. JOURNAL OF VIROLOGY, 2002, 76 (06) : 2997 - 3006
[32] CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs
Kitadokoro, K
Bordo, D
Galli, G
Petracca, R
Falugi, F
Abrignani, S
Grandi, G
Bolognesi, M
[J]. EMBO JOURNAL, 2001, 20 (1-2) : 12 - 18
[33] Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
Kolykhalov, AA
Agapov, EV
Blight, KJ
Mihalik, K
Feinstone, SM
Rice, CM
[J]. SCIENCE, 1997, 277 (5325) : 570 - 574
[34] Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo
Kolykhalov, AA
Mihalik, K
Feinstone, SM
Rice, CM
[J]. JOURNAL OF VIROLOGY, 2000, 74 (04) : 2046 - 2051
[35] Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
Kuhn, RJ
Zhang, W
Rossmann, MG
Pletnev, SV
Corver, J
Lenches, E
Jones, CT
Mukhopadhyay, S
Chipman, PR
Strauss, EG
Baker, TS
Strauss, JH
[J]. CELL, 2002, 108 (05) : 717 - 725
[36] AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS
KUO, G
CHOO, QL
ALTER, HJ
GITNICK, GL
REDEKER, AG
PURCELL, RH
MIYAMURA, T
DIENSTAG, JL
ALTER, MJ
STEVENS, CE
TEGTMEIER, GE
BONINO, F
COLOMBO, M
LEE, WS
KUO, C
BERGER, K
SHUSTER, JR
OVERBY, LR
BRADLEY, DW
HOUGHTON, M
[J]. SCIENCE, 1989, 244 (4902) : 362 - 364
[37] Kwong AD, 2000, CURR TOP MICROBIOL, V242, P171
[38] Advances in model systems for hepatitis C virus research
Lanford, RE
Bigger, C
[J]. VIROLOGY, 2002, 293 (01) : 1 - 9
[39] Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes
Lanford, RE
Chavez, D
Guerra, B
Lau, JYN
Hong, Z
Brasky, KM
Beames, B
[J]. JOURNAL OF VIROLOGY, 2001, 75 (17) : 8074 - 8081
[40] Medical progress: Hepatitis C virus infection.
Lauer, GM
Walker, BD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) : 41 - 52

← 1 2 3 4 5 6 7 8 →